**Charity registration number 802164**
**Company registration number 01700787 (England and Wales)**
## **THE SOCIETY OF MUSCULOSKELETAL MEDICINE**
# **COMPANY LIMITED BY GUARANTEE ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021**
**THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE LEGAL AND ADMINISTRATIVE INFORMATION**
**Trustees** Dr E L Atkins MBE Dr G Cameron Miss F M Ottewell Dr D A Reid Mr J P Smith (Appointed 13 June 2022) Mr N Worth **Charity number** 802164 **Company number** 01700787 **Principal address** Somm 4th Floor 151 Dale Street Liverpool L2 2AH **Registered office** Somm 4th Floor 151 Dale Street Liverpool L2 2AH **Independent Examiner:** Jean Ellis BA FCA CTA DSG Castle Chambers 43 Castle Street Liverpool L2 9TL **Bankers** Charities Aid Foundation 10 St Bride Street London EC4A 4AD **Investment advisors** Quilter Cheviot Limited One Kingsway, London, WC2B 6AN
## **THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE CONTENTS**
||**Page**|
|---|---|
|Trustees' report|1 - 5|
|Statement of trustees' responsibilities|6|
|Independent examiner's report|7|
|Statement of financial activities|8|
|Balance sheet|9|
|Notes to the financial statements|10 - 17|
**THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT)** _**FOR THE YEAR ENDED 31 DECEMBER 2021**_
The trustees present their annual report and financial statements for the year ended 31 December 2021.
The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's governing document, the Companies Act 2006 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)".
## **Objectives and activities**
The Society of Musculoskeletal Medicine (SOMM) - formerly the Society of Orthopaedic Medicine - is an educational charitable company that was formed in 1979 to develop the seminal work of Dr James Cyriax MRCP and to promote the theory and the practice of musculoskeletal medicine.
SOMM provides a comprehensive programme of post graduate courses for physiotherapists and doctors that run primarily throughout the UK but invitations further afield are always considered and courses in Europe and South East Asia have been delivered in the past.
The Society has a committed team of tutors who have many years of experience practicing musculoskeletal medicine in many different arenas - NHS, sport, private practice and the armed forces. This brings diversity and interest in the courses and ensures a stimulating and varied learning experience.
The main objective of the Society during the past 12 months has been to recover from the impact of the Covid 19 Pandemic and to sustain our ability to provide high quality musculoskeletal medicine training to result in better medical treatment for patients.
Our strategy has continued to focus on the need to;
1. Strengthen existing offering to current markets - such as increasing our ‘virtual ‘capacity
2. Develop new offerings to current markets- such as online teaching and ‘covid safe’ courses and HEE ( Health Education England) accreditation
3. Identify new markets for the current offering -such as HEE Supervision and Top Up day
## **Public Benefit**
The objects for which The Society of Musculoskeletal Medicine has been established are:
_To benefit the public through the promotion and advancement of musculoskeletal medicine. We will provide education to facilitate the practice, study and publication of research within this field._
The trustees have paid due regard to the Charity Commission guidance on public benefit in deciding SOMM activities to be undertaken and have only pursued activities with a public benefit outlined below.
The core activity of the Society is the teaching of musculoskeletal medicine through Foundation course modules, which aim to provide students with a practical approach to the clinical diagnosis and treatment of musculoskeletal conditions.
The outcome is a public benefit through being diagnosed or treated by medical practitioners or allied health professionals that are trained in SOMM principles and subsequently have confidence to practise this important area of medicine.
There is public benefit gained through sharing knowledge in this way so that patients receive the best possible diagnosis and treatment from fully informed doctors and allied health professionals.
- 1 -
**THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2021**_
## **Achievements and performance**
SOMM started to re-stablish face to face training during 2021.
We also addressed the need to sustain our teaching capacity following the loss of some key tutors.
During the last financial year, the Society managed to deliver 8 diploma module courses, 152 students attended the SOMM Diploma in Musculoskeletal Medicine.
The Society also provided further courses for students that have completed the diploma, encompassing modules on The Theory and Practice of Injection Therapy and Advancing Clinical Practice in Musculoskeletal Medicine.
We had 16 advanced modules (injection therapy, special tests etc) with 272 students.
Our collaboration with Queen Margaret University, Edinburgh continued with 2 students enrolling on the MSc Musculoskeletal Medicine in 2021.
Therefore, a total of 424 students were trained by SOMM in 2021.
## **Financial review**
Total income for the period was £241,738 (2020: £125,091).
Total expenditure for the period was £250,915 (2020: £178,529).
Our investments during the year (see note 10) meant that we generated a small surplus for the period of £29,734 (2020: deficit for the year of £44,511)
At the end of 2021 the fixed assets were valued at £265,112 (2020: 252,165).
The Society has a current account which at the year-end totalled £48,213 (in 2020 this was £53,288)
## **Reserves policy**
It is the policy of the charity that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to between three and six month’s expenditure. The trustees consider that reserves at this level will ensure that, in the event of a significant drop in funding, they will be able to continue the charity’s current activities while consideration is given to ways in which additional funds may be raised. This level of reserves has been maintained throughout the year.
## **Investment policy**
£260,549 is held in a broad range of investment fund, with an overarching conservative objective in order to minimise risk and safeguard the funds. This has had a demonstrable impact with funds generating income during the last year. Quilter Cheviot is the appointed investment advisor, and they manage SOMM funds on a discretionary basis. This enables an improved speed of decision-making as the appointed investment managers are authorised to move funds according to market conditions.
The Council has requested that portfolio of investments be managed cautiously, within agreed parameters, and improved performance has resulted. The Society Manager and Treasurer receive regular investment performance reports from Cheviot Asset Management, and can access real time valuations at any given juncture
- 2 -
## **THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2021**_
## **Risk policy**
The Council has assessed the major risks to which the charitable company is exposed.
These have been identified as follows:
- Covid 19 pandemic disrupting Business as Usual
- Dependency on key personnel - ensure that succession planning is in place
- Failure of course programme, declining number of students/ Covid 19
- Dependency on key funders, NHS constraints and failure to meet funding target
- Poor investment performance
The following measures were implemented to address these risks:
- Establishment of online training tools
- Established delivery of covid secure courses
- Established ability to work and meet and train virtually
- SOMM training offer to Students in Norway
• Continue our relationship with our appointed investment manager, who has the authority to act on a discretionary basis, to reinvest funds (with agreed parameters) to maximize current market conditions. The Society Manager and Treasurer receive regular reports from our appointed investments manager and have real time access to the valuation of SOMM's portfolio and can monitor performance on a daily basis if required.
The Council is satisfied that HR, legal, IT and Health & Safety obligations currently have sufficient control systems in place.
All risks continue to be thoroughly reviewed annually.
## **Structure, governance and management**
The organisation is a charitable company; limited by guarantee (registered in England and Wales No.01700787) originally formed in 1979 and was incorporated on 11th January 1983. The company was established under a Memorandum of Association, which established the objects and powers of the company and is governed by its Articles of Association.
The charitable company was registered with the Charities Commission (registered number 802164) on 17th January 1990 as a charity for the benefit of the public in relieving sickness by promoting and advancing the use, study and science of orthopaedic medicine and by providing facilities for treatment, education, study and research therein.
The charitable company changed its name from The Society of Orthopaedic Medicine on 21 st January 2013.
- 3 -
**THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2021**_
The trustees, who are also the directors for the purpose of company law, and who served during the year and up to the date of signature of the financial statements were:
Dr E L Atkins MBE Dr G Cameron Mrs E J Goodlad (Resigned 17 February 2022) Mr D Muir (Resigned 29 August 2022) Miss F M Ottewell Dr D A Reid Dr F Shaikh (Resigned 22 July 2021) Mr J P Smith (Appointed 13 June 2022) Mr N Worth
Members of the Council are elected/re-elected at the Annual General Meeting by the membership. According to SOMM’s constitution, 1/3 of elected Councillors will retire by rotation at each Annual General Meeting, with those that have been longest in office being first to retire. Officers of the Society are exempt from retiring for re-election partway through their term of office.
Some of the trustees are remunerated by the Society of Musculoskeletal Medicine (SOMM) for their professional services in teaching musculoskeletal medicine on behalf of SOMM. The Society governance includes strict policies and procedures that are in place to safeguard the organisation against any potential conflict of interest that might arise through such remuneration. No Council members are remunerated for their trusteeship services.
## **Trustee Recruitment and Appointment**
SOMM’s constitution requires that Councillors be elected to office by the membership. A call for nominations was sent to all SOMM members in advance of the Annual General Meeting. Additionally, SOMM Council has the power to co-opt individuals. All co-options are valid for 1 year until the date of the next Annual General Meeting, at which point Council may decide to renew the co-option.
## **Trustee Induction and Training**
All newly-elected trustees are sent an induction pack which includes the following items:
1. Trustee job description
2. Council terms of reference
3. Minutes from last twelve months council meetings
4. SOMM governance review
5. SOMM constitution
6. Business plan
7. Risk assessment
8. Charity Trustee’s Handbook
9. Code of Good Governance
10. SOMM contacts list
11. Charity Commission information and link to their website
12. Council performance review
SOMM trustees are the main decision-makers for the organisation, and the trustee board is known as Council. Trustees are updated on SOMM activities and performance through regular email communications from the Society Manager, at Council meetings, strategic planning meetings, and any other ad hoc meetings. Subcommittees include the Education Committee and Research Committee. All Committees have specific Terms of Reference which outline their responsibilities and reporting structure. All sub-committees report to SOMM Council.
- 4 -
## **THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2021**_
Council has agreed a target that all incoming trustees should attend formal trustee training, and has also proactively encouraged current trustees to attend such training. To date, 50% of current trustees either have already received formal training or are planning to attend a training course in the coming year.
The Society Manager manages the performance and administration of the organisation, and attends all Council and Committee meetings.
Annual budgets are prepared by the Society Manager in collaboration with the office lead for finances and the Treasurer for approval by Council.
Council receives regular management accounts reports throughout the year.
Council has delegated authority for financial decisions up to the value of £10,000 to the Treasurer, and Society Manager, providing there is unanimity across the group. This policy is beneficial operationally because it enables timely decisions to be made and implemented.
Many action points have arisen including increasing financial, business and marketing skills on the Council, clarifying the relative roles of Society Manager and Council, increasing strategic activity, improving communications and decision-making.
## **Small company provisions**
This report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.
The trustees' report was approved by the Board of Trustees.
## **Miss F M Ottewell**
Trustees Dated: 27 October 2022
- 5 -
## **THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE STATEMENT OF TRUSTEES' RESPONSIBILITIES**
## _**FOR THE YEAR ENDED 31 DECEMBER 2021**_
The trustees, who are also the directors of The Society Of Musculoskeletal Medicine for the purpose of company law, are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company Law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that year.
In preparing these financial statements, the trustees are required to:
- select suitable accounting policies and then apply them consistently;
- observe the methods and principles in the Charities SORP;
- make judgements and estimates that are reasonable and prudent; and
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in operation.
The trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
- 6 -
## **THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE INDEPENDENT EXAMINER'S REPORT**
## **TO THE TRUSTEES OF THE SOCIETY OF MUSCULOSKELETAL MEDICINE**
I report to the trustees on my examination of the financial statements of The Society Of Musculoskeletal Medicine (the charity) for the year ended 31 December 2021.
This report is made solely to the charity’s trustees, as a body, in accordance with section 145 of the Charities Act 2011. My work has been undertaken so that I might state to the charity’s trustees those matters I am required to state to them in this report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the charity and the charity’s trustees as a body, for my work, for this report, or for the opinions I have formed.
## **Responsibilities and basis of report**
As the trustees of the charity (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 (the 2006 Act).
Having satisfied myself that the financial statements of the charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the charity’s financial statements carried out under section 145 of the Charities Act 2011 (the 2011 Act). In carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
## **Independent examiner's statement**
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
- 1 accounting records were not kept in respect of the charity as required by section 386 of the 2006 Act; or
- 2 the financial statements do not accord with those records; or
- 3 the financial statements do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or
- 4 the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.
Jean Ellis BA FCA CTA DSG
Castle Chambers 43 Castle Street Liverpool L2 9TL
Dated: 27 October 2022
- 7 -
## **THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT**
## _**FOR THE YEAR ENDED 31 DECEMBER 2021**_
|||||**Unrestricted **|**Unrestricted**|**Unrestricted**|
|---|---|---|---|---|---|---|
|||||**funds**||**funds**|
|||||**2021**||**2020**|
||||**Notes**|**£**||**£**|
|**Income from:**|||||||
|Donations and legacies|||**3**|1,000||10,000|
|Charitable activities|||**4**|235,894||110,488|
|Investments|||**5**|4,844||4,603|
||||||||
|**Total income**||||241,738||125,091|
||||||||
|**Expenditure on:**|||||||
|Raising funds|||**6**|2,326||2,026|
|Charitable activities|||**7**|248,589||176,503|
||||||||
|**Total expenditure**||||250,915||178,529|
||||||||
|Net deficit for the year||||(9,177)||(53,438)|
|Net gains/(losses)||on investments|**10**|38,911||8,927|
||||||||
|**Net movement in**||**funds**||29,734||(44,511)|
|**Reconciliation**|**of**|**funds**|||||
|Fund balances at 1 January 2021||||195,440||239,951|
||||||||
|**Fund balances at 31 December 2021**||||225,174||195,440|
The statement of financial activities includes all gains and losses recognised in the year.
All income and expenditure derive from continuing activities.
The statement of financial activities also complies with the requirements for an income and expenditure account under the Companies Act 2006.
- 8 -
## **THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE BALANCE SHEET**
## _**AS AT 31 DECEMBER 2021**_
|||**2021**|||**2020**|||
|---|---|---|---|---|---|---|---|
||**Notes**|**£**|**£**||**£**|**£**||
|**Fixed assets**||||||||
|Tangible assets|**11**||4,563|||3,044||
|Investments|**12**||260,549|||249,121||
|||||||||
||||265,112|||252,165||
|**Current assets**||||||||
|Stocks|**14**|1,435|||-|||
|Debtors|**15**|16,602|||17,809|||
|Cash at bank and in hand||48,213|||53,288|||
|||||||||
|||66,250|||71,097|||
|**Creditors: amounts falling due within**||||||||
|**one year**|**16**|(106,188)|||(127,822)|||
|||||||||
|Net current liabilities|||(39,938)|||(56,725)||
|||||||||
|**Total assets less current liabilities**|||225,174|||195,440||
|**Income funds**||||||||
|Unrestricted funds|||225,174|||195,440||
|||||||||
||||225,174|||195,440||
The company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 31 December 2021.
The Trustees acknowledge their responsibilities for ensuring that the charity keeps accounting records which comply with section 386 of the Act and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its incoming resources and application of resources, including its income and expenditure, for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the Trustees on 27 October 2022
Miss F M Ottewell **Trustee**
**Company registration number 01700787**
- 9 -
**THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS**
## _**FOR THE YEAR ENDED 31 DECEMBER 2021**_
## **1 Accounting policies**
## **Charity information**
The Society of Musculoskeletal Medicine is private limited company limited by guarantee registered in England and Wales. The registered office address is 4th floor 151 Dale Street Liverpool L2 2AH.
## **1.1 Accounting convention**
The financial statements have been prepared in accordance with the charity's governing document, the Companies Act 2006 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)". The charity is a Public Benefit Entity as defined by FRS 102.
The charity has taken advantage of the provisions in the SORP for charities applying FRS 102 Update Bulletin 1 not to prepare a Statement of Cash Flows.
The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
## **1.2 Going concern**
At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.
## **1.3 Charitable funds**
Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.
## **1.4 Income**
Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.
Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.
Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.
## **1.5 Expenditure**
Liabilities are recognised as soon as there is a legal or constructive obligation committing the charitable company to that expenditure, it is probable that settlement will be required and the amount of the obligation can be measured reliably
- 10 -
**THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2021**_
## **1 Accounting policies**
## **(Continued)**
## **1.6 Tangible fixed assets**
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant and equipment 25% reducing balance Fixtures and fittings 25% reducing balance Computers 25% reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.
## **1.7 Fixed asset investments**
Fixed asset investments are initially measured at transaction price excluding transaction costs, and are subsequently measured at fair value at each reporting date. Changes in fair value are recognised in net income/(expenditure) for the year. Transaction costs are expensed as incurred.
## **1.8 Impairment of fixed assets**
At each reporting end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).
## **1.9 Stocks**
Stocks are valued at the lower of cost or selling price less selling costs, after making due allowance for obsolete and slow-moving items. Cost is calculated using the first-in first-out basis of valuation.
## **1.10 Cash and cash equivalents**
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
## **1.11 Financial instruments**
The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
## _**Basic financial assets**_
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
- 11 -
**THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2021**_
## **1 Accounting policies**
## **(Continued)**
## _**Basic financial liabilities**_
Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
## _**Derecognition of financial liabilities**_
Financial liabilities are derecognised when the charity’s contractual obligations expire or are discharged or cancelled.
## **1.12 Employee benefits**
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
## **1.13 Retirement benefits**
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
## **2 Critical accounting estimates and judgements**
In the application of the charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
## **3 Donations and legacies**
||**Unrestricted**|Unrestricted|
|---|---|---|
||**funds**|funds|
||**2021**|2020|
||**£**|£|
|Covid Grant|1,000|10,000|
- 12 -
## **THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2021**_
## **4 Charitable activities**
||**2021**|**2020**|
|---|---|---|
||**£**|**£**|
|Income from charitable activities|228,600|103,115|
|Income from beneficiaries services|5,044|7,133|
|Other income|2,250|240|
||||
||235,894|110,488|
## **5 Investments**
||**Unrestricted**|Unrestricted|
|---|---|---|
||**funds**|funds|
||**2021**|2020|
||**£**|£|
|Income from listed investments|4,843|4,596|
|Interest receivable|1|7|
||||
||4,844|4,603|
## **6 Raising funds**
|||**Unrestricted**|Unrestricted|
|---|---|---|---|
|||**funds**|funds|
|||**2021**|2020|
|||**£**|£|
|Investment|management|2,326|2,026|
|||||
|||2,326|2,026|
- 13 -
**THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2021**_
## **7 Charitable activities**
||**2021**|**2020**|
|---|---|---|
||**£**|**£**|
|Staff costs|56,724|63,079|
|Depreciation and impairment|1,524|1,015|
|Temporary staff|-|597|
|Printing, postage and stationery|2,212|3,184|
|Telephone and interent|2,318|179|
|Insurance|209|640|
|Promotion and advertising|969|654|
|Rent and rates|7,399|7,676|
|Computer and website costs|1,960|2,603|
|Subscriptions|7,529|7,188|
|Repairs and renewals|2,700|-|
|Meeting costs|3,076|5,010|
|General expenses|4,399|1,126|
|Bank charges|2,961|3,392|
|Legal and professional fees|488|4,129|
|Accountancy|1,440|1,440|
|Courses and examination costs|152,681|74,591|
||||
||248,589|176,503|
## **8 Trustees**
None of the trustees (or any persons connected with them) received any remuneration or benefits from the charity during the year (2020 - none).
## **9 Employees**
The average monthly number of employees during the year was:
|The average monthly number of employees during the year was:||||
|---|---|---|---|
||**2021**||**2020**|
||**Number**||**Number**|
|Charitable activities|2||2|
|**Employment costs**|**2021**||**2020**|
||**£**||**£**|
|Wages and salaries|55,299||60,745|
|Social security costs|876||1,567|
|Other pension costs|549||767|
|||||
||56,724||63,079|
- 14 -
**THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2021**_
## **9 Employees**
## **(Continued)**
There were no employees whose annual remuneration was more than £60,000.
## **10 Net gains/(losses) on investments**
||**Unrestricted**|Unrestricted|
|---|---|---|
||**funds**|funds|
||**2021**|2020|
||**£**|£|
|Revaluation of investments|30,683|20,352|
|Gain/(loss) on sale of investments|8,228|(11,425)|
||||
||38,911|8,927|
## **11 Tangible fixed assets**
|**Tangible fixed assets**|||||||||
|---|---|---|---|---|---|---|---|---|
||**Plant and**||
**Fixtures and**||
**Computers**|||**Total**|
||**equipment**|||**fittings**|||||
|||**£**||**£**||**£**||**£**|
|**Cost**|||||||||
|At 1 January 2021||5,646||8,254||2,941||16,841|
|Additions||-||-||3,043||3,043|
||||||||||
|At 31 December 2021||5,646||8,254||5,984||19,884|
||||||||||
|**Depreciation and impairment**|||||||||
|At 1 January 2021||5,534||7,528||735||13,797|
|Depreciation charged in the year||30||182||1,312||1,524|
||||||||||
|At 31 December 2021||5,564||7,710||2,047||15,321|
||||||||||
|**Carrying amount**|||||||||
|At 31 December 2021||82||544||3,937||4,563|
|At 31 December 2020||112||726||2,206||3,044|
- 15 -
**THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2021**_
## **12 Fixed asset investments**
|||||**Listed**|
|---|---|---|---|---|
||||**investments**||
|||||**£**|
||**Cost or valuation**||||
||At 1 January 2021|||249,121|
||Additions|||48,223|
||Valuation changes|||30,602|
||Movement in capital and cash accounts|||(2,131)|
||Disposals|||(65,266)|
||||||
||At 31 December 2021|||260,549|
||||||
||**Carrying amount**||||
||At 31 December 2021|||260,549|
||At 31 December 2020|||249,121|
|**13**|**Financial instruments**|**2021**||**2020**|
|||**£**||**£**|
||**Carrying amount of financial assets**||||
||Instruments measured at fair value through the statement of financial activities|260,549||249,121|
|**14**|**Stocks**||||
|||**2021**||**2020**|
|||**£**||**£**|
||Finished goods and goods for resale|1,435||-|
|**15**|**Debtors**||||
|||**2021**||**2020**|
||**Amounts falling due within one year:**|**£**||**£**|
||Trade debtors|7,720||5,749|
||Other debtors|2,422||2,547|
||Prepayments and accrued income|6,460||9,513|
||||||
|||16,602||17,809|
- 16 -
## **THE SOCIETY OF MUSCULOSKELETAL MEDICINE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 31 DECEMBER 2021**_
## **16 Creditors: amounts falling due within one year**
|||**2021**|**2020**|
|---|---|---|---|
||**Notes**|**£**|**£**|
|Deferred income||53,744|87,439|
|Trade creditors||31,266|33,556|
|Other creditors||18,373|5,387|
|Accruals||2,805|1,440|
|||||
|||106,188|127,822|
Deferred income of £53,744 (2020: £87,439) relates to income received for future periods.
## **17 Related party transactions**
There were no disclosable related party transactions during the year (2020 - none).
- 17 -